Patent · US Active

Truncated ACTRIIB-FC fusion protein

US9181533B2 · kind B2 · utility

22Cited by
55References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 2012
Grant dateNov 10, 2015
Priority date
Expiry dateDec 6, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/1103
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, brown fat and/or neuronal tissue and for treating metabolic disorders such as diabetes and obesity, as well as disorders associated with any of the foregoing tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.